Hofbieber\/Munich (DE), Antwerp (BE) \u2014 Gimv invests in the Apra\u00adxon Group, a leading home\u00adcare company focu\u00adsed on wound care in Germany. The tran\u00adsac\u00adtion, which has alre\u00adady been comple\u00adted, is part of a joint growth plan with the company\u2019s foun\u00adder and CEO, Oliver Pokrze\u00adwin\u00adski, who will conti\u00adnue to be a key share\u00adhol\u00adder in the company.<\/p>\n
Apra\u00adxon, (Hofbie\u00adber (DE) \u2014 apraxon.com), offers high-quality wound care for (mainly elderly) people with chro\u00adnic wounds in the home\u00adcare sector. Typi\u00adcal wound indi\u00adca\u00adti\u00adons are decu\u00adbi\u00adtus, diabe\u00adtic foot or ulcus cruris. In this context, the company acts as a link between pati\u00adents, doctors, nursing service\/home and the health insu\u00adrance companies.<\/p>\n
Due to its high degree of specia\u00adliza\u00adtion, Apra\u00adxon provi\u00addes a conti\u00adnuously high quality of medi\u00adcal care and is able to tailor the treat\u00adment process to the indi\u00advi\u00addual needs of each pati\u00adent. In a market with steadily rising pati\u00adent numbers, driven prima\u00adrily by demo\u00adgra\u00adphic change, specia\u00adli\u00adzed medi\u00adcal care is beco\u00adming incre\u00adasingly important. The services are reim\u00adbur\u00adsed by health insu\u00adrance compa\u00adnies, for which Apra\u00adxon has been a relia\u00adble part\u00adner for many years.<\/p>\n
\u201cI am convin\u00adced that Gimv is the right part\u00adner to realize the company\u2019s growth ambi\u00adti\u00adons and expand Apra\u00adxon\u2019s presence in Germany,\u201d said Oliver Pokrze\u00adwin\u00adski, Mana\u00adging Direc\u00adtor and CEO of Apraxon.<\/p>\n
\u201cThanks to Apra\u00adxon\u2019s clear commit\u00adment to quality, the above-average quali\u00adfi\u00adca\u00adtion of their nursing staff and their highly digi\u00adta\u00adli\u00adzed and scalable proces\u00adses, we are convin\u00adced that Apra\u00adxon is the right plat\u00adform to build a true market leader in German wound care. We are very much looking forward to support\u00ading Mr. Pokrze\u00adwin\u00adski and the entire Apra\u00adxon team in imple\u00admen\u00adting their ambi\u00adtious growth plans,\u201d says Phil\u00adipp v. Hammer\u00adstein, Part\u00adner at Gimv in the Health & Care team in Munich.<\/p>\n
The new invest\u00adment is alre\u00adady Gimv\u2019s fifth acqui\u00adsi\u00adtion in the German-spea\u00adking health\u00adcare market within the last four years. Gimv curr\u00adently holds a total of 23 invest\u00adments in compa\u00adnies in the health\u00adcare and life scien\u00adces sector. With this acqui\u00adsi\u00adtion, Gimv once again under\u00adlines its posi\u00adtion as one of the most active Euro\u00adpean inves\u00adtors in the health\u00adcare indus\u00adtry and its ambi\u00adtion to posi\u00adtively contri\u00adbute to the United Nati\u00adons goals; in this case \u201cHealth and Well\u00adbe\u00ading\u201d. The Gimv port\u00adfo\u00adlio also includes seve\u00adral hospi\u00adtal and prac\u00adtice groups as well as medi\u00adcal tech\u00adno\u00adlogy and biotech companies.<\/p>\n
ABOUT GIMV<\/strong> Gimv iden\u00adti\u00adfies inno\u00adva\u00adtive, leading compa\u00adnies with high growth poten\u00adtial and supports them sustain\u00adably on their way to market leader\u00adship. Each of the four invest\u00adment plat\u00adforms Consu\u00admer, Health & Care, Smart Indus\u00adtries and Sustainable Cities is mana\u00adged by a dedi\u00adca\u00adted and compe\u00adtent team, each based in Gimv\u2019s home markets \u2014 Bene\u00adlux, France and DACH \u2014 and supported by an exten\u00adsive inter\u00adna\u00adtio\u00adnal network of experts.<\/p>\n","protected":false},"excerpt":{"rendered":" Hofbieber\/Munich (DE), Antwerp (BE) \u2014 Gimv invests in the Apra\u00adxon Group, a leading home\u00adcare company focu\u00adsed on wound care in Germany. The tran\u00adsac\u00adtion, which has alre\u00adady been comple\u00adted, is part of a joint growth plan with the company\u2019s foun\u00adder and CEO, Oliver Pokrze\u00adwin\u00adski, who will conti\u00adnue to be a key share\u00adhol\u00adder in the company. Apraxon, [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":37155,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1369,1371],"tags":[],"class_list":["post-43458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-investors","category-deals-en","news-category-private-equity-news-en"],"yoast_head":"\n
\nGimv is a Euro\u00adpean invest\u00adment company with 40 years of expe\u00adri\u00adence in private equity. The company is listed on Euron\u00adext Brussels, curr\u00adently mana\u00adges around EUR 2.0 billion and curr\u00adently invests in 55 port\u00adfo\u00adlio compa\u00adnies, which toge\u00adther gene\u00adrate reve\u00adnues of more than EUR 2.5 billion and employ 14,000 people. Gimv\u2019s aspi\u00adra\u00adtion to make a posi\u00adtive value contri\u00adbu\u00adtion to society is reflec\u00adted, among other things, in the recently successfully laun\u00adched Sustainable Bond.<\/p>\n